Identification of Hypoxia-Associated Signature in Colon Cancer to Assess Tumor Immune Microenvironment and Predict Prognosis Based on 14 Hypoxia-Associated Genes

References

• Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71. doi:10.1016/j.canlet.2017.04.024
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Comprehen Cancer Network. 2018;16(4):359–369. doi:10.6004/jnccn.2018.0021
   PubMed Web of Science ®Google Scholar
• Gupta R, Bhatt LK, Johnston TP, et al. Colon cancer stem cells: potential target for the treatment of colorectal cancer. Cancer Biol Ther. 2019;20(8):1068–1082. doi:10.1080/15384047.2019.1599660
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (Concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075. doi:10.1016/S0140-6736(17)33326-3
   PubMed Web of Science ®Google Scholar
• Chen H, Luo J, Guo J. Development and validation of a five-immune gene prognostic risk model in colon cancer. BMC Cancer. 2020;20(1):395. doi:10.1186/s12885-020-06799-0
   PubMed Web of Science ®Google Scholar
• Multhoff G, Vaupel P. Hypoxia compromises anti-cancer immune responses. Adv Exp Med Biol. 2020;1232:131–143.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33(4):207–214. doi:10.1016/j.tips.2012.01.005
   PubMed Web of Science ®Google Scholar
• Zhang B, Tang B, Gao J, et al. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients. J Transl Med. 2020;18(1):342. doi:10.1186/s12967-020-02492-9
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4566. doi:10.1158/0008-5472.CAN-18-3962
   PubMed Web of Science ®Google Scholar
• Liu G, Rui W, Zhao X, et al. Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment. Cell Mol Immunol. 2021;18(5):1085–1095. doi:10.1038/s41423-021-00655-2
   PubMed Web of Science ®Google Scholar
• Balsamo M, Manzini C, Pietra G, et al. Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC. Eur J Immunol. 2013;43(10):2756–2764. doi:10.1002/eji.201343448
   PubMed Web of Science ®Google Scholar
• Terry S, Buart S, Chouaib S. Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity. Front Immunol. 2017;8:1625. doi:10.3389/fimmu.2017.01625
   PubMed Web of Science ®Google Scholar
• Westendorf AM, Skibbe K, Adamczyk A, et al. Hypoxia enhances immunosuppression by inhibiting CD4+ effector T cell function and promoting treg activity. Cell Physiol Biochem. 2017;41(4):1271–1284. doi:10.1159/000464429
   PubMedGoogle Scholar
• Liberzon A, Birger C, Thorvaldsdóttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–425. doi:10.1016/j.cels.2015.12.004
   PubMed Web of Science ®Google Scholar
• Zlobec I, Steele R, Nigam N, et al. A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods. Clin Cancer Res. 2005;11(15):5440–5443. doi:10.1158/1078-0432.CCR-04-2587
   PubMed Web of Science ®Google Scholar
• Li YM, Li ZL, Chen F, et al. A LASSO-derived risk model for long-term mortality in Chinese patients with acute coronary syndrome. J Transl Med. 2020;18(1):157. doi:10.1186/s12967-020-02319-7
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Pinello N, Sun S, Wong JJ. Aberrant expression of enzymes regulating m(6)A mRNA methylation: implication in cancer. Cancer Biol Med. 2018;15(4):323–334. doi:10.20892/j.issn.2095-3941.2018.0365
   PubMed Web of Science ®Google Scholar
• Tong J, Cao G, Zhang T, et al. m(6)A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28(2):253–256. doi:10.1038/cr.2018.7
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1–10. doi:10.1016/j.immuni.2013.07.012
   PubMed Web of Science ®Google Scholar
• Xu L, Deng C, Pang B, et al. TIP: a Web Server for Resolving Tumor Immunophenotype Profiling. Cancer Res. 2018;78(23):6575–6580. doi:10.1158/0008-5472.CAN-18-0689
   PubMed Web of Science ®Google Scholar
• Buttacavoli M, Di Cara G, Roz E, et al. Integrated multi-omics investigations of metalloproteinases in colon cancer: focus on MMP2 and MMP9. Int J Mol Sci. 2021;22(22):12389. doi:10.3390/ijms222212389
   PubMed Web of Science ®Google Scholar
• Yue B, Qiu S, Zhao S, et al. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis. J Gastroenterol Hepatol. 2016;31(3):595–603. doi:10.1111/jgh.13206
   PubMed Web of Science ®Google Scholar
• Zhou H, Zou J, Shao C, et al. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway. Pathol Res Pract. 2022;230:153749. doi:10.1016/j.prp.2021.153749
   PubMed Web of Science ®Google Scholar
• Zhdanov AV, Dmitriev RI, Papkovsky DB. Bafilomycin A1 activates HIF-dependent signalling in human colon cancer cells via mitochondrial uncoupling. Biosci Rep. 2012;32(6):587–595. doi:10.1042/BSR20120085
   PubMed Web of Science ®Google Scholar
• Zheng S, Zou Y, Liang JY, et al. Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer. Mol Oncol. 2020;14(11):2814–2833. doi:10.1002/1878-0261.12747
   PubMed Web of Science ®Google Scholar
• Jahanafrooz Z, Mosafer J, Akbari M, et al. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. J Cell Physiol. 2020;235(5):4153–4166. doi:10.1002/jcp.29337
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23(10):2479–2516. doi:10.1093/annonc/mds236
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhang J, Zeng D, et al. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer. Cancer Immunol Immunother. 2019;68(3):433–442. doi:10.1007/s00262-018-2289-7
   PubMed Web of Science ®Google Scholar
• Wang X, Xu Y, Li T, et al. Development of prognosis model for colon cancer based on autophagy-related genes. World J Surg Oncol. 2020;18(1):285. doi:10.1186/s12957-020-02061-w
   PubMed Web of Science ®Google Scholar
• van Pelt GW, Sandberg TP, Morreau H, et al. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology. 2018;73(2):197–206. doi:10.1111/his.13489
   PubMed Web of Science ®Google Scholar
• Xia X, Wang S, Ni B, et al. Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop. Oncogene. 2020;39(39):6231–6244. doi:10.1038/s41388-020-01425-6
   PubMed Web of Science ®Google Scholar
• Tao J, Yang G, Zhou W, et al. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14(1):14.
   PubMed Web of Science ®Google Scholar
• de Heer EC, Jalving M, Harris AL. HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. J Clin Invest. 2020;130(10):5074–5087. doi:10.1172/JCI137552
   PubMed Web of Science ®Google Scholar
• Xu Y, Cao C, Zhu Z, et al. Novel hypoxia-associated gene signature depicts tumor immune microenvironment and predicts prognosis of colon cancer patients. Front Genet. 2022;13:901734.
   PubMedGoogle Scholar
• Huang HC, Lin WR, Lim SN, et al. Aldolase triggers metabolic reprogramming in colorectal cancer in hypoxia and stiff desmoplastic microenvironments. Colloids Surf B Biointerfaces. 2020;190:110969. doi:10.1016/j.colsurfb.2020.110969
   PubMed Web of Science ®Google Scholar
• Zong S, Li W, Li H, et al. Identification of hypoxia-regulated angiogenic genes in colorectal cancer. Biochem Biophys Res Commun. 2017;493(1):461–467. doi:10.1016/j.bbrc.2017.08.169
   PubMed Web of Science ®Google Scholar
• Zhou X, Shang YN, Lu R, et al. High ANKZF1 expression is associated with poor overall survival and recurrence-free survival in colon cancer. Future Oncol. 2019;15(18):2093–2106. doi:10.2217/fon-2018-0920
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Mao X, Brown-Clay J, et al. Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2. Sci Rep. 2018;8(1):10191. doi:10.1038/s41598-018-28637-x
   PubMedGoogle Scholar
• Chen L, Long X, Duan S, et al. CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways. Theranostics. 2020;10(24):11063–11079. doi:10.7150/thno.45674
   PubMed Web of Science ®Google Scholar
• Liu T, Laurell C, Selivanova G, et al. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis. Cell Death Differ. 2007;14(3):411–421. doi:10.1038/sj.cdd.4402022
   PubMed Web of Science ®Google Scholar
• Pan X, Wu H, Chen G, et al. Prognostic value of enolase gene family in colon cancer. Med Sci Monit. 2020;26:e922980. doi:10.12659/MSM.922980
   PubMed Web of Science ®Google Scholar
• Cha MK, Kim IH. Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma. Cancer Epidemiol. 2009;33(3–4):281–287. doi:10.1016/j.canep.2009.08.006
   PubMed Web of Science ®Google Scholar
• Papiewska-Pająk I, Krzyżanowski D, Katela M, et al. Glypican-1 level is elevated in extracellular vesicles released from MC38 colon adenocarcinoma cells overexpressing snail. Cells. 2020;9(7):1585. doi:10.3390/cells9071585
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang S, Wang Y, et al. Effects of hypoxia in intestinal tumors on immune cell behavior in the tumor microenvironment. Front Immunol. 2021;12:645320.
   PubMed Web of Science ®Google Scholar
• Tudisco L, Orlandi A, Tarallo V, et al. Hypoxia activates placental growth factor expression in lymphatic endothelial cells. Oncotarget. 2017;8(20):32873–32883. doi:10.18632/oncotarget.15861
   PubMedGoogle Scholar
• Unterleuthner D, Neuhold P, Schwarz K, et al. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis. 2020;23(2):159–177. doi:10.1007/s10456-019-09688-8
   PubMed Web of Science ®Google Scholar
• Yang F, Cai S, Ling L, et al. Identification of a five-gene prognostic model and its potential drug repurposing in colorectal cancer based on TCGA, GTEx and GEO databases. Front Genet. 2020;11:622659.
   PubMed Web of Science ®Google Scholar
• Uddin MN, Li M, Wang X. Identification of transcriptional signatures of colon tumor stroma by a meta-analysis. J Oncol. 2019;2019:1–12. doi:10.1155/2019/8752862
   Web of Science ®Google Scholar
• Nakayama K, Qi J, Ronai Z. The ubiquitin ligase Siah2 and the hypoxia response. Mol Cancer Res. 2009;7(4):443–451. doi:10.1158/1541-7786.MCR-08-0458
   PubMed Web of Science ®Google Scholar
• Bruno T, Valerio M, Casadei L, et al. Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization. J Exp Clin Cancer Res. 2017;36(1):32. doi:10.1186/s13046-017-0497-1
   PubMedGoogle Scholar
• Miyazaki S, Kikuchi H, Iino I, et al. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts. Int J Cancer. 2014;135(2):295–307. doi:10.1002/ijc.28686
   PubMed Web of Science ®Google Scholar
• Chen B, Zeng X, He Y, et al. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7(44):71400–71416. doi:10.18632/oncotarget.12147
   PubMedGoogle Scholar
• Bentz S, Cee A, Endlicher E, et al. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Digestion. 2013;88(3):182–192. doi:10.1159/000355015
   PubMed Web of Science ®Google Scholar
• Hu LH, Yang JH, Zhang DT, et al. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs. 2007;18(4):427–433. doi:10.1097/CAD.0b013e328013d99e
   PubMed Web of Science ®Google Scholar
• Langbein S, Zerilli M, Zur Hausen A, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: warburg effect reinterpreted. Br J Cancer. 2006;94(4):578–585. doi:10.1038/sj.bjc.6602962
   PubMed Web of Science ®Google Scholar
• Deng J, Li J, Sarde A, et al. Hypoxia-induced vista promotes the suppressive function of myeloid-derived suppressor cells in the tumor microenvironment. Cancer Immunol Res. 2019;7(7):1079–1090. doi:10.1158/2326-6066.CIR-18-0507
   PubMed Web of Science ®Google Scholar
• Joshi S, Liu KX. Macrophage Syk-PI3Kγ inhibits antitumor immunity: SRX3207, a novel dual Syk-PI3K inhibitory chemotype relieves tumor immunosuppression. Mol Cancer Ther. 2020;19(3):755–764. doi:10.1158/1535-7163.MCT-19-0947
   PubMed Web of Science ®Google Scholar
• Toor SM, Sasidharan Nair V, Decock J, et al. Immune checkpoints in the tumor microenvironment. Semin Cancer Biol. 2020;65:1–12. doi:10.1016/j.semcancer.2019.06.021
   PubMed Web of Science ®Google Scholar
• Miao D, Margolis CA, Gao W. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science. 2018;359(6377):801–806. doi:10.1126/science.aan5951
   PubMed Web of Science ®Google Scholar
• Zengin Kurt B, Sonmez F, Ozturk D, et al. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. Eur J Med Chem. 2019;183:111702. doi:10.1016/j.ejmech.2019.111702
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, Ahmad R, Abdulla M, et al. Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents. Eur J Med Chem. 2016;109:247–253. doi:10.1016/j.ejmech.2016.01.001
   PubMed Web of Science ®Google Scholar